Skip to main content

Month: February 2021

OP Ryhmän tilinpäätöstiedote 1.1.–31.12.2020: Tulos ennen veroja 785 miljoonaa euroa – korkokate ja vakuutuskate kasvoivat epävarmassa toimintaympäristössä

OP RyhmäTilinpäätöstiedote 1.1.–31.12.2020Pörssitiedote 10.2.2021 klo 9.00OP Ryhmän tilinpäätöstiedote 1.1.–31.12.2020: Tulos ennen veroja 785 miljoonaa euroa – korkokate ja vakuutuskate kasvoivat epävarmassa toimintaympäristössäTulos ennen veroja oli 785 miljoonaa euroa (838).Asiakasliiketoiminnan tuotoista korkokate kasvoi 4 % 1 284 miljoonaan euroon (1 241) ja vakuutuskate 36 % 572 miljoonaan euroon (421). Nettopalkkiotuotot olivat 931 miljoonaa euroa (936).Koronaviruspandemian (COVID-19) aiheuttama sijoitusmarkkinoiden kehitys laski sijoitustoiminnan tuottoja varsinkin ensimmäisellä vuosineljänneksellä. Tuotot sijoitustoiminnasta laskivat vertailukaudesta 58 % 181 miljoonaan euroon (425).Yhteensä tuotot laskivat 3 % 3 103 miljoonaan euroon (3 181).Kulut laskivat 3 % 1 839 miljoonaan euroon (1 903). Lakisääteisen työeläkevastuun loppuosan...

Continue reading

OP Gruppens bokslutskommuniké 1.1–31.12.2020: Resultatet före skatt 785 miljoner euro – räntenettot och försäkringsnettot ökade i den osäkra omvärlden

OP GruppenBokslutskommuniké 1.1–31.12.2020Börsmeddelande 10.2.2021 kl. 9.00OP Gruppens bokslutskommuniké 1.1–31.12.2020: Resultatet före skatt 785 miljoner euro – räntenettot och försäkringsnettot ökade i den osäkra omvärldenResultatet före skatt var 785 miljoner euro (838).Bland intäkterna från kundrörelsen ökade räntenettot med 4 % till 1 284 miljoner euro (1 241) och försäkringsnettot med 36 % till 572 miljoner euro (421). Provisionsnettot uppgick till 931 miljoner euro (936).Utvecklingen på placeringsmarknaden till följd av coronapandemin (COVID-19) minskade intäkterna från placeringsverksamheten särskilt under det första kvartalet. Intäkterna från placeringsverksamhet minskade från jämförelseperioden med 58 % till 181 miljoner euro (425).Totalt minskade intäkterna med 3 % till 3 103 miljoner euro (3 181).Kostnaderna minskade med...

Continue reading

Invitation to BTS Q4 report 2020 presentation and conference call

P R E S S  R E L E A S EStockholm, February 10th, 2021STOCKHOLM, SWEDEN – BTS Group AB (publ), a leading global strategy implementation firm, invites investors, analysts and business journalists to a combined interim report presentation and conference call with CEO Henrik Ekelund.Conference call and web link: Wednesday, February 24th at 09.30 am CET. The presentation can be followed via the web with opportunities to ask questions. Please dial any of the following numbers:UK +44 333 300 9264US +1 833 526 8396SE +46-8-566 427 06Follow the presentation via the link below:https://tv.streamfabriken.com/bts-group-q4-2020Registration is not required for participation via the webcast or conference call.The report is published at 08.00 am CET the same day.The presentation including the slides will be available later athttp://ir.bts.com/presentationsHead...

Continue reading

Inbjudan till BTS Q4 2020 presentation och telefonkonferens

P R E S S R E L E A S EStockholm, 10 februari 2021STOCKHOLM, SVERIGE – BTS GROUP AB (publ), ett världsledande företag inom strategigenomförande, bjuder in investerare, analytiker och ekonomijournalister till en kombinerad rapportpresentation och telefonkonferens med VD Henrik Ekelund.Telefonkonferens och webblänk: Onsdagen den 24 februari klockan 09.30. Presentationen av rapporten sker på engelska via webblänk med möjlighet att ställa frågor. Vänligen ring något av följande nummer:SE 08-566 427 06UK +44 333 300 9264US +1-833 526 8396Följ presentationen via länken nedan:https://tv.streamfabriken.com/bts-group-q4-2020För att delta via webbsändningen eller telefonkonferensen krävs ingen anmälan.Rapporten publiceras klockan 08.00 samma dag.Presentation samt presentationsmaterial kommer att finnas tillgängliga i efterhand påhttp://ir.bts.com/presentationsFör...

Continue reading

Biophytis annonce la suspension temporaire du cours de ses actions ordinaires et de ses bons de souscription d’actions sur Euronext Growth

PARIS et CAMBRIDGE, Mass., 10 févr. 2021 (GLOBE NEWSWIRE) — BIOPHYTIS SA (Euronext Growth Paris : ALBPS), société de biotechnologie au stade clinique, spécialisée dans le développement de traitements qui ralentissent les processus dégénératifs liés au vieillissement et qui améliorent les résultats fonctionnels des patients souffrant de maladies liées à l’âge, y compris l’insuffisance respiratoire chez les patients souffrant de la COVID-19, annonce aujourd’hui que le cours de bourse de ses actions ordinaires et de ses bons de souscription d’actions sur le marché d’Euronext Growth à Paris sera temporairement suspendu à sa demande, à compter de l’ouverture à 9h00 CET. Cette suspension intervient dans le cadre de l’introduction en bourse de la Société sur le Nasdaq Capital Market, afin de permettre la confirmation des allocations...

Continue reading

Biophytis Announces Temporary Trading Halt of its Ordinary Shares and Share Warrants on Euronext Growth

PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) — Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, announces today that trading of its ordinary shares and share warrants on Euronext Growth will be temporarily halted at the Company’s request from the opening of the market at 9 a.m. CET in the context of its initial public offering on the Nasdaq Capital Market in order to allow for the confirmation of allocations to investors and for the commencement of trading of the Company’s American Depositary Shares...

Continue reading

Biophytis Announces Pricing of $20.1 Million U.S. Initial Public Offering of American Depositary Shares and Approval to List on Nasdaq Capital Market

PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) — Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces the pricing of its previously announced U.S. initial public offering of 12,000,000 new ordinary shares represented by 1,200,000 American Depositary Shares (“ADSs”), with each ADS representing 10 ordinary shares, at an initial public offering price of $16.75 per ADS (the “ADS Offering”). The aggregate gross proceeds from the ADS Offering are expected to be $20.1 million, before deducting the...

Continue reading

Biophytis annonce la Fixation du Prix de son Offre ADS et l’Approbation de l’Admission aux Négociations sur le Nasdaq Capital Market

PARIS et CAMBRIDGE, Mass., 10 févr. 2021 (GLOBE NEWSWIRE) — BIOPHYTIS SA (Euronext Growth Paris : ALBPS), (« Biophytis » ou la « Société »), société de biotechnologie au stade clinique, spécialisée dans le développement de traitements qui ralentissent les processus dégénératifs liés au vieillissement et qui améliorent les résultats fonctionnels des patients souffrant de maladies liées à l’âge, y compris l’insuffisance respiratoire chez les patients souffrant de la COVID-19, annonce aujourd’hui la fixation du prix de son introduction en bourse sur le Nasdaq Capital Market par le biais d’une augmentation de capital de 12 000 000 nouvelles actions ordinaires (les « Actions Nouvelles ») sous la forme d’American Depositary Shares (les « ADS »), chacune d’entre elles représentant dix actions ordinaires (l’ « Offre ADS »),...

Continue reading

JLT Mobile Computers opens customer pilot program for new Android 10‑based rugged vehicle‑mount computer

Based on JLT’s latest generation product platform and the Qualcomm® Snapdragon™ 660 RISC processor, the new JLT6012A computer is perfectly positioned to address the growing demand for Android vehicle‑mount computers in the warehousing and logistics segmentVäxjö, Sweden, 10 February 2021 * * * JLT Mobile Computers, a leading supplier of reliable computers for demanding environments, announces the launch of a pilot program for its state-of-the-art Android 10‑based JLT6012A vehicle‑mount computer designed to boost productivity in warehousing and other logistics deployments. Bringing Android 10 to the popular JLT6012 platform brings convenience and exciting new opportunity into forklifts and many other types of vehicles. JLT delivered its first advance JLT6012A unit to a customer last month and additional interested customers can now apply...

Continue reading

JLT Mobile Computers startar pilotprogram för ny Android 10-baserad, ruggad, fordonsmonterad dator

Den nya JLT6012A-datorn är baserad på den senaste generationen av JLT:s produktplattform och Qualcomm®:s Snapdragon™ 660 RISC-processor, och fyller ett växande behov av fordonsmonterade datorer med Android inom lager- och logistiksegmentetVäxjö, Sverige, 10:e februari 2021   * * *   JLT Mobile Computers, ledande leverantör av stryktåliga datorer för krävande miljöer, lanserar ett pilotprogram för sin toppmoderna Android 10-baserade, fordonsmonterade JLT6012A-dator som tagits fram för att öka produktiviteten i lageranläggningar och annan logistikverksamhet. Android 10 i kombination med den populära JLT6012-plattformen erbjuder flera fördelar och spännande nya möjligheter i gaffeltruckar och många andra typer av fordon. JLT levererade det första förserie-exemplaret av JLT6012A-datorn under föregående månad och andra intresserade kunder...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.